Whipplewood Advisors LLC purchased a new position in ARK Genomic Revolution ETF (BATS:ARKG – Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 12,933 shares of the company’s stock, valued at approximately $305,000.
A number of other hedge funds also recently bought and sold shares of the company. Hemington Wealth Management raised its holdings in ARK Genomic Revolution ETF by 44.6% in the fourth quarter. Hemington Wealth Management now owns 1,310 shares of the company’s stock worth $30,000 after buying an additional 404 shares during the last quarter. Union Bancaire Privee UBP SA bought a new stake in shares of ARK Genomic Revolution ETF during the fourth quarter valued at approximately $45,000. National Bank of Canada FI raised its holdings in ARK Genomic Revolution ETF by 28.4% in the 3rd quarter. National Bank of Canada FI now owns 4,155 shares of the company’s stock worth $106,000 after acquiring an additional 920 shares during the last quarter. ARK Investment Management LLC lifted its position in ARK Genomic Revolution ETF by 72.7% in the 4th quarter. ARK Investment Management LLC now owns 5,989 shares of the company’s stock valued at $141,000 after acquiring an additional 2,521 shares in the last quarter. Finally, IHT Wealth Management LLC purchased a new stake in ARK Genomic Revolution ETF during the 3rd quarter valued at $203,000.
ARK Genomic Revolution ETF Price Performance
ARK Genomic Revolution ETF stock opened at $25.63 on Thursday. The business has a 50 day simple moving average of $25.90 and a two-hundred day simple moving average of $25.41.
ARK Genomic Revolution ETF Profile
The ARK Genomic Revolution ETF (ARKG) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund is an actively managed fund that targets companies involved in the genomics industry. ARKG was launched on Oct 31, 2014 and is managed by ARK.
See Also
- Five stocks we like better than ARK Genomic Revolution ETF
- How to Invest in Insurance Companies: A Guide
- Buffett’s on the Sidelines – Should You Follow?
- 5 Top Rated Dividend Stocks to Consider
- AST SpaceMobile Stock Surges 17% After Analyst Upgrade
- How to Start Investing in Real Estate
- 3 Stocks With Triple-Digit PEs That Are Still Worth a Look
Want to see what other hedge funds are holding ARKG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ARK Genomic Revolution ETF (BATS:ARKG – Free Report).
Receive News & Ratings for ARK Genomic Revolution ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ARK Genomic Revolution ETF and related companies with MarketBeat.com's FREE daily email newsletter.
